BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//YourSite//YourCalendar//EN
BEGIN:VEVENT
UID:6a575a21a018b@yourdomain.com
DTSTAMP:20260715T100001Z
DTSTART;VALUE=DATE:20241010
DTEND;VALUE=DATE:20241011
SUMMARY:LSX Nordics 2024 Interview
DESCRIPTION:The LSX - partnering for Life Science eXecutives congress, Director of Immuno-Oncology & Preclinical Development, Stine Friis, shared Evaxion's recent achievements on large pharma deals and the promising data from our Phase 2 personalized cancer vaccine trial, highlighting the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets.
LOCATION:Copenhagen, Denmark
END:VEVENT
END:VCALENDAR